Publication | Closed Access

The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions

OncologyAngiogenesisAnti-cancer Drug LenalidomideMedicineEndothelial Cell FunctionVascular BiologyPharmacotherapyAnti-cancer AgentCancer TreatmentHypoxic ConditionsPharmacologyRadiation OncologyTumor MicroenvironmentCancer Research